Focus Partners Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561M Buy
1,140,952
+196,196
+21% +$106M 0.62% 32
2025
Q4
$547M Buy
944,756
+686,009
+265% +$388M 0.62% 34
2025
Q3
$126M Buy
258,747
+2,947
+1% +$1.37M 0.2% 91
2025
Q2
$104M Buy
255,800
+36,179
+16% +$15.1M 0.22% 94
2025
Q1
$109M Buy
219,621
+247
+0.1% +$134K 0.27% 76
2024
Q4
$114M Buy
219,374
+3,682
+2% +$2.02M 0.3% 66
2024
Q3
$133M Sell
215,692
-186,432
-46% -$110M 0.43% 47
2024
Q2
$222M Buy
402,124
+378,030
+1,569% +$217M 0.75% 28
2024
Q1
$14M Buy
24,094
+5,363
+29% +$3.01M 0.11% 177
2023
Q4
$9.94M Buy
+18,731
New +$9.07M 0.13% 152

Other funds holding TMO

Focus Partners Wealth's TMO Position: Q1 2026 in Review

Focus Partners Wealth increased its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, buying an estimated $106M and bringing the position to 1,140,952 shares worth $561M. The position accounts for 0.62% of the portfolio, ranked #32.

Focus Partners Wealth first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Focus Partners Wealth held 1,140,952 shares of Thermo Fisher Scientific worth $561M as of Q1 2026.
  • Focus Partners Wealth bought 196,196 Thermo Fisher Scientific shares in Q1 2026, an estimated $106M.
  • Thermo Fisher Scientific made up 0.62% of Focus Partners Wealth's portfolio in Q1 2026, its #32 holding.
  • Focus Partners Wealth first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.